REG - BkofA Merrill Lynch AbbVie Inc. - Form 38.5 (b) - AbbVie Inc
FORM 38.5(b)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT
RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNIZED INTERMEDIARY
STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY
1.
KEY INFORMATION
Name of exempt principal trader
BofA Securities, Inc.
Company dealt in
AbbVie Inc
Class of relevant security to which the
dealings being disclosed relate(Note 1)Common - US00287Y1091
Date of dealing
29/04/2020
2.
INTERESTS AND SHORT POSITIONS
(a)
Interests and short positions (following dealing) in the class of relevant security
dealt in (Note 2)
Class of relevant security: Common
US00287Y1091
Long
Short
Number
%
Number
%
(1)
Relevant securities
204,430
0.014%
3,390,137
0.23 %
(2)
Derivatives (other than options):
2,565,553
0.174%
193,957
0.013%
(3)
Options and agreements to purchase/sell:
7,400
0.001%
7,500
0.001%
Total
2,777,383
0.188%
3,591,594
0.243%
(b)
Interests and short positions in relevant securities of the company, other than the
class dealt in (Note 2)
Class of relevant security:
Long
Short
Number
%
Number
%
(1)
Relevant securities
0
0%
0
0%
(2)
Derivatives (other than options):
0
0%
0
0%
(3)
Options and agreements to purchase/sell:
0
0%
0
0%
Total
0
0%
0
0%
3.
DEALINGS (Note 3)
(a)
Purchases and sales
Purchase/sale
Number of relevant securities
Price per unit (Note 4)
Purchase
2,784
83.76 USD
Purchase
1
82.2 USD
Purchase
1
82.28 USD
Purchase
22
82.29 USD
Purchase
33
82.31 USD
Purchase
24
82.32 USD
Purchase
200
82.36 USD
Purchase
56
82.37 USD
Purchase
100
82.38 USD
Purchase
24
82.42 USD
Purchase
500
82.45 USD
Purchase
1
82.46 USD
Purchase
1
82.48 USD
Purchase
100
82.49 USD
Purchase
100
82.5 USD
Purchase
2
82.52 USD
Purchase
1
82.53 USD
Purchase
33
82.55 USD
Purchase
2
82.57 USD
Purchase
33
82.59 USD
Purchase
1
82.6 USD
Purchase
2
82.61 USD
Purchase
24
82.62 USD
Purchase
34
82.63 USD
Purchase
1
82.64 USD
Purchase
1
82.65 USD
Purchase
55
82.66 USD
Purchase
1
82.68 USD
Purchase
2
82.69 USD
Purchase
1
82.72 USD
Purchase
123
82.73 USD
Purchase
1
82.74 USD
Purchase
1
82.75 USD
Purchase
532
82.76 USD
Purchase
35
82.77 USD
Purchase
1
82.78 USD
Purchase
25
82.79 USD
Purchase
35
82.8 USD
Purchase
100
82.84 USD
Purchase
200
82.85 USD
Purchase
201
82.86 USD
Purchase
100
82.9 USD
Purchase
22
82.91 USD
Purchase
55
82.94 USD
Purchase
1
83.07 USD
Purchase
5
83.12 USD
Purchase
14
83.13 USD
Purchase
22
83.14 USD
Purchase
41
83.25 USD
Purchase
2
83.32 USD
Purchase
40
83.4 USD
Purchase
1
83.41 USD
Purchase
40
83.62 USD
Purchase
25
83.67 USD
Purchase
25
83.7 USD
Purchase
25
83.71 USD
Purchase
25
83.72 USD
Purchase
71
83.74 USD
Purchase
2,745
83.76 USD
Purchase
25
83.77 USD
Purchase
25
83.78 USD
Purchase
35
83.79 USD
Purchase
48
83.8 USD
Purchase
17
83.81 USD
Purchase
17
83.82 USD
Purchase
117
83.83 USD
Purchase
17
83.87 USD
Purchase
33
83.88 USD
Purchase
34
83.94 USD
Purchase
252
83.95 USD
Purchase
57
83.96 USD
Purchase
29
83.965 USD
Purchase
68
83.97 USD
Purchase
29
83.975 USD
Purchase
61
83.98 USD
Purchase
137
83.99 USD
Purchase
50
84 USD
Purchase
163
84.01 USD
Purchase
79
84.02 USD
Purchase
116
84.03 USD
Purchase
1,800
84.035 USD
Purchase
58
84.04 USD
Purchase
106
84.05 USD
Purchase
4
84.055 USD
Purchase
140
84.06 USD
Purchase
142
84.07 USD
Purchase
206
84.08 USD
Purchase
125
84.09 USD
Purchase
234
84.1 USD
Purchase
129
84.11 USD
Purchase
1
84.12 USD
Purchase
221
84.13 USD
Purchase
165
84.14 USD
Purchase
281
84.16 USD
Purchase
1
84.17 USD
Purchase
101
84.18 USD
Purchase
118
84.2 USD
Purchase
33
84.21 USD
Purchase
1
84.22 USD
Purchase
174
84.23 USD
Purchase
112
84.24 USD
Purchase
33
84.25 USD
Purchase
33
84.26 USD
Purchase
73
84.27 USD
Purchase
100
84.28 USD
Purchase
100
84.29 USD
Purchase
26
84.31 USD
Purchase
300
84.33 USD
Purchase
401
84.34 USD
Purchase
100
84.35 USD
Purchase
100
84.36 USD
Purchase
100
84.37 USD
Purchase
33
84.4 USD
Purchase
33
84.45 USD
Purchase
40
84.49 USD
Purchase
1
84.51 USD
Purchase
34
84.6 USD
Purchase
33
84.68 USD
Purchase/sale
Number of relevant securities
Price per unit (Note 4)
Sale
100
82.26 USD
Sale
276
82.27 USD
Sale
87
82.28 USD
Sale
86
82.29 USD
Sale
86
82.3 USD
Sale
549
82.31 USD
Sale
3
82.315 USD
Sale
300
82.32 USD
Sale
113
82.34 USD
Sale
289
82.35 USD
Sale
379
82.36 USD
Sale
286
82.37 USD
Sale
400
82.38 USD
Sale
470
82.39 USD
Sale
106
82.4 USD
Sale
802
82.41 USD
Sale
188
82.42 USD
Sale
503
82.43 USD
Sale
373
82.44 USD
Sale
100
82.441 USD
Sale
574
82.45 USD
Sale
2,722
82.46 USD
Sale
550
82.47 USD
Sale
653
82.48 USD
Sale
778
82.49 USD
Sale
711
82.5 USD
Sale
73
82.501 USD
Sale
3
82.505 USD
Sale
375
82.51 USD
Sale
1,074
82.52 USD
Sale
100
82.525 USD
Sale
744
82.53 USD
Sale
101
82.54 USD
Sale
167
82.55 USD
Sale
651
82.56 USD
Sale
100
82.565 USD
Sale
606
82.57 USD
Sale
100
82.575 USD
Sale
213
82.58 USD
Sale
615
82.59 USD
Sale
2
82.595 USD
Sale
1
82.6 USD
Sale
200
82.605 USD
Sale
737
82.61 USD
Sale
124
82.62 USD
Sale
286
82.63 USD
Sale
577
82.64 USD
Sale
6
82.65 USD
Sale
173
82.66 USD
Sale
232
82.67 USD
Sale
268
82.68 USD
Sale
267
82.69 USD
Sale
359
82.7 USD
Sale
145
82.71 USD
Sale
145
82.72 USD
Sale
262
82.73 USD
Sale
87
82.74 USD
Sale
575
82.75 USD
Sale
643
82.76 USD
Sale
200
82.78 USD
Sale
328
82.81 USD
Sale
173
82.815 USD
Sale
478
82.82 USD
Sale
958
82.83 USD
Sale
347
82.84 USD
Sale
1,354
82.85 USD
Sale
300
82.855 USD
Sale
940
82.86 USD
Sale
791
82.87 USD
Sale
186
82.89 USD
Sale
482
82.9 USD
Sale
84
82.91 USD
Sale
469
82.92 USD
Sale
100
82.93 USD
Sale
173
82.96 USD
Sale
200
82.97 USD
Sale
100
82.98 USD
Sale
43
83.01 USD
Sale
187
83.02 USD
Sale
146
83.03 USD
Sale
400
83.04 USD
Sale
14
83.1 USD
Sale
117
83.11 USD
Sale
13
83.13 USD
Sale
110
83.14 USD
Sale
100
83.15 USD
Sale
134
83.16 USD
Sale
378
83.17 USD
Sale
88
83.18 USD
Sale
601
83.19 USD
Sale
88
83.195 USD
Sale
333
83.2 USD
Sale
179
83.21 USD
Sale
469
83.22 USD
Sale
404
83.23 USD
Sale
100
83.24 USD
Sale
86
83.25 USD
Sale
187
83.26 USD
Sale
447
83.27 USD
Sale
103
83.28 USD
Sale
8
83.29 USD
Sale
299
83.3 USD
Sale
512
83.31 USD
Sale
263
83.32 USD
Sale
12
83.34 USD
Sale
100
83.36 USD
Sale
177
83.37 USD
Sale
200
83.38 USD
Sale
100
83.39 USD
Sale
100
83.4 USD
Sale
74
83.46 USD
Sale
200
83.47 USD
Sale
547
83.48 USD
Sale
300
83.49 USD
Sale
274
83.5 USD
Sale
269
83.51 USD
Sale
174
83.52 USD
Sale
100
83.53 USD
Sale
100
83.54 USD
Sale
40
83.56 USD
Sale
100
83.57 USD
Sale
264
83.58 USD
Sale
307
83.59 USD
Sale
100
83.6 USD
Sale
192
83.601 USD
Sale
334
83.61 USD
Sale
3,500
83.613 USD
Sale
237
83.62 USD
Sale
100
83.625 USD
Sale
100
83.63 USD
Sale
149
83.64 USD
Sale
1
83.675 USD
Sale
86
83.68 USD
Sale
111
83.69 USD
Sale
12
83.705 USD
Sale
53
83.71 USD
Sale
13
83.75 USD
Sale
2,691
83.76 USD
Sale
101
83.79 USD
Sale
116
83.8 USD
Sale
60
83.91 USD
Sale
12
83.93 USD
Sale
32
83.95 USD
Sale
11
83.96 USD
Sale
100
83.99 USD
Sale
6
84.02 USD
Sale
247
84.03 USD
Sale
359
84.04 USD
Sale
359
84.05 USD
Sale
173
84.07 USD
Sale
100
84.075 USD
Sale
100
84.08 USD
Sale
3,861
84.09 USD
Sale
644
84.1 USD
Sale
813
84.11 USD
Sale
738
84.12 USD
Sale
95
84.13 USD
Sale
735
84.14 USD
Sale
95
84.145 USD
Sale
1,075
84.15 USD
Sale
100
84.155 USD
Sale
800
84.16 USD
Sale
460
84.165 USD
Sale
819
84.17 USD
Sale
192
84.18 USD
Sale
939
84.19 USD
Sale
814
84.2 USD
Sale
100
84.205 USD
Sale
181
84.21 USD
Sale
62
84.22 USD
Sale
101
84.25 USD
Sale
673
84.26 USD
Sale
446
84.27 USD
Sale
100
84.28 USD
Sale
1
84.29 USD
Sale
124
84.3 USD
Sale
50
84.31 USD
Sale
107
84.32 USD
Sale
115
84.34 USD
Sale
174
84.35 USD
Sale
86
84.36 USD
Sale
187
84.37 USD
Sale
87
84.4 USD
Sale
5
84.41 USD
Sale
71
84.42 USD
Sale
602
84.44 USD
Sale
100
84.45 USD
Sale
100
84.46 USD
Sale
361
84.47 USD
Sale
56
84.48 USD
Sale
500
84.49 USD
Sale
100
84.5 USD
Sale
100
84.51 USD
Sale
173
84.52 USD
Sale
26
84.53 USD
Sale
100
84.61 USD
Sale
18
84.63 USD
Sale
100
82.84 USD
Sale
200
82.85 USD
Sale
200
82.86 USD
Sale
100
82.9 USD
Sale
55
82.94 USD
Sale
8,429
83.87 USD
(b)
Derivatives transactions (other than options transactions)
Product name,
e.g. CFDNature of transaction
(Note 5)Number of relevant securities
(Note 6)Price per unit
(Note 4)Swaps
Increasing a Long Position
3,500
83.613 USD
(c)
Options transactions in respect of existing relevant securities
(i)
Writing, selling, purchasing or varying
Product name, e.g. call option
Writing, selling, purchasing, varying etc.
Number of securities to which the option relates (Note 7)
Exercise price
Type, e.g. American, European etc
Expiry date
Option money paid/ received per unit (Note 4)
N/A
N/A
N/A
N/A
N/A
N/A
N/A
(ii)
Exercising
Product name,
e.g. call optionNumber of securities
Exercise price per
unit (Note 4)N/A
N/A
N/A
(d)
Other dealings (including transactions in respect of new securities) (Note 3)
Nature or transaction
(Note 7)Details
Price per unit
(if applicable) (Note 4)
Borrow
Borrow of 938,700 shares
N/A
Borrow
Borrow of 100 shares
N/A
4.
OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting rights
or future acquisition or disposal of any relevant securities to which any derivative
referred to on this form is referenced. If none, this should be stated.None
Is a Supplemental Form 38.5(b) attached? (Note 8)
Yes
Date of disclosure
30/04/2020
Contact name
Tolu Tade
Telephone number
+44207 996 3410
Name of offeree/offeror with which connected
AbbVie Inc
Nature of connection (Note 9)
Advisor to - AbbVie Inc
SUPPLEMENTAL FORM 38.5(b)
DISCLOSURE UNDER RULE 38.5 (b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
Product name,
e.g. call optionWritten or
purchasedNumber of securities to which the option or derivative relates
Exercise price
(Note 2)Type, e.g.
American,
European etcExpiry date
Call Option
Written
7,500
105 USD
American
15/01/2021
Call Option
Purchased
7,400
85 USD
American
15/01/2021
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDISEKBLBXBZLEBBF
Recent news on Abbvie
See all newsRCS - Ripple Therapeutics - Ripple Therapeutics Announces Collaboration
AnnouncementREG - Stock Exch Notice - Admission to ISM - 20/06/2024
AnnouncementREG - JPMorgan Inv. Trusts - Ten Largest Investments
AnnouncementREG - JPMorgan Inv. Trusts - Ten Largest Investments
AnnouncementREG - JPMorgan Inv. Trusts - Ten Largest Investments
Announcement